Arcturus Therapeutics Holdings IncARCT
Price$13.69Intrinsic value$10.9920% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $10.99median of 2 methodsbased on filings through 30 Jun 2026
Market Price $13.69Price as of 30 Sep 2026
Margin of Safety -19.7%as of 30 Sep 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: -16.1%/yr (balance of the path).-12.3% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 6-12.3%Yr 7-8.5%Yr 8-4.7%Yr 9-0.8%Yr 103.0%
-16.1% → 3.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 113.0%Yr 123.0%Yr 133.0%Yr 143.0%Yr 153.0%Yr 163.0%Yr 173.0%Yr 183.0%Yr 193.0%Yr 203.0%
3.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 13.3%
Volatility vs market (adjusted beta)1.85

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetArcturus Therapeutics Holdings IncARCTHealth Care
Valuation
P/E—
P/S15.5×
P/B2.7×
EV / Revenue9.5×
EV / EBITDA-25.7×
Profitability
Gross margin100.0%
Operating margin-1,403.7%
Net margin-317.6%
FCF margin-248.0%
Returns
ROE-54.3%
ROA-41.6%
ROIC—
Growth
Revenue growth (YoY)-80.7%
5-yr fwd EPS growth-12.3%
Financial strength
Debt / Equity0.09×
Current ratio5.88×
Altman Z-Score0.6
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.